enGene Holdings Inc.

NASDAQ: ENGN · Healthcare · Biotechnology

Canadian filerHQ Saint-Laurent, CIK 0001980845Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 44DQ —GM —SS 43

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, market scale · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$117.3M

Employees

Market cap

$91.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$117.3M-$117.3M2025

Operating income-$123.2M-$123.2M2025

Total assets$221.5M$221.5M2025

Liabilities$53.8M$53.8M2025

Equity$167.7M$167.7M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

enGene Holdings Inc. earned -$117.3M in FY2025 net income.

Peers · Healthcare

SANUWAVE Health Inc.74B Rallybio Corporation47D Oncolytics Biotech Inc.——vTv Therapeutics Inc.57C

Key facts

CEORonald H. W. Cooper

SectorHealthcare

IndustryBiotechnology

HeadquartersSaint-Laurent, null

ExchangeNASDAQ: ENGN

Employees56

IPO date2022-02-01

Latest filings

8-K2026-06-15 10-Q2026-06-15 8-K2026-06-10 DEF 14A2026-05-08 8-K2026-05-07 8-K2026-04-09 10-Q2026-03-09 8-K2026-03-09

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.